Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023459
Filing Date
2016-08-09
Accepted
2016-08-09 06:07:38
Documents
60
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agle-10q_20160630.htm 10-Q 1644718
2 EX-31.1 agle-ex311_8.htm EX-31.1 14581
3 EX-31.2 agle-ex312_6.htm EX-31.2 14174
4 EX-32.1 agle-ex321_7.htm EX-32.1 6826
5 EX-32.2 agle-ex322_9.htm EX-32.2 6841
  Complete submission text file 0001564590-16-023459.txt   5477054

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agle-20160630.xml EX-101.INS 1070156
7 XBRL TAXONOMY EXTENSION SCHEMA agle-20160630.xsd EX-101.SCH 42792
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agle-20160630_cal.xml EX-101.CAL 34683
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agle-20160630_def.xml EX-101.DEF 173367
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20160630_lab.xml EX-101.LAB 319460
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20160630_pre.xml EX-101.PRE 250830
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 161815940
SIC: 2834 Pharmaceutical Preparations